BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
JMIA
Jumia Technologies AG
JMIA has a slight edge over BABA overall, supported by stronger fundamentals and stronger modeled upside.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
JMIA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
JMIA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
JMIA PE Valuation
JMIA has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
JMIA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect JMIA's losses to shrink, with revenue growing.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over JMIA on earnings quality, reporting a profit while its opponent remains loss making.
JMIA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.94 | +$0.08 |
| Q1 2026 | -$1.03 | -$0.07 |
| Q4 2025 | -$1.03 | +$0.05 |
| Q3 2025 | -$1.18 | -$0.25 |
| Q2 2025 | -$1.02 | -$0.01 |
| Q1 2025 | -$0.96 | +$0.15 |
| Q4 2024 | -$1.08 | -$0.05 |
| Q3 2024 | -$0.93 | +$0.49 |
JMIA is still losing money, but far less than before: $0.94 per share over the past year, against $3.65 at its worst in late 2019.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over JMIA on profitability, with a higher operating margin.
JMIA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $51.9M | +14% |
| Q1 2026 | $50.6M | +39% |
| Q4 2025 | $61.3M | +34% |
| Q3 2025 | $45.6M | +25% |
| Q2 2025 | $45.6M | +25% |
| Q1 2025 | $36.3M | -26% |
| Q4 2024 | $45.7M | -2.2% |
| Q3 2024 | $36.4M | -13% |
JMIA's revenue is recovering but still below its 2020 peak: $52M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -24% | +12 points |
| Q1 2026 | -27% | +24 points |
| Q4 2025 | -19% | +19 points |
| Q3 2025 | -38% | +17 points |
| Q2 2025 | -36% | +19 points |
| Q1 2025 | -51% | -34 points |
| Q4 2024 | -38% | -37 points |
| Q3 2024 | -55% | -11 points |
JMIA's operating margin was −24% last quarter, up 12 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
JMIA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$12.3M | +$1.1M |
| Q1 2026 | -$13.1M | +$9M |
| Q4 2025 | -$3.4M | +$25M |
| Q3 2025 | -$13.8M | +$13.9M |
| Q2 2025 | -$13.4M | -$4.3M |
| Q1 2025 | -$22M | -620% |
| Q4 2024 | -$28.4M | -$18.3M |
| Q3 2024 | -$27.7M | -$3.3M |
JMIA has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
JMIA Net Leverage
JMIA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
JMIA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 18.2 | Oversold |
JMIA's weekly RSI is 39 (neutral) and its Stochastic is 18 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
JMIA PE vs Consumer Cyclical Sector
JMIA has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
JMIA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.99 | 6% below |
| 20 week MA | $6.40 | 12% below |
| 50 week MA | $8.05 | 30% below |
| 100 week MA | $6.84 | 18% below |
| 200 week MA | $5.66 | 0.5% below |
JMIA is in a downtrend: it's below all five of its weekly moving averages, and 0.5% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over JMIA on returns for 2026, with the stronger performance.
JMIA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.13 | $43.6 | +612% |
| 2021 | $43.6 | $12.4 | -72% |
| 2022 | $12.4 | $3.21 | -74% |
| 2023 | $3.21 | $3.53 | +10% |
| 2024 | $3.53 | $4.01 | +14% |
| 2025 | $4.01 | $12.0 | +198% |
| 2026 YTD | $12.0 | $5.63 | -53% |
JMIA's yearly returns have swung widely, from +612% in 2020 to −74% in 2022. It's down 53% so far in 2026.